You can buy or sell Erytech Pharma and other stocks, options, ETFs, and crypto commission-free!
Erytech Pharma S.A. American Depositary Shares, also called Erytech Pharma, is a biopharmaceutical company, which develops medical products. Read More It engages in developing and producing therapeutic products for cancer and orphan diseases. The company was founded by Pierre-Olivier Goineau and Yann Godfrin on November 22, 2004 and is headquartered in Lyon, France.
52 Week High
52 Week Low
Seeking AlphaMar 12
ERYTECH Pharma S.A. (ERYP) CEO Gil Beyen on Q4 2018 Results - Earnings Call Transcript
ERYTECH Pharma S.A. (NASDAQ:ERYP) Q4 2018 Earnings Conference Call March 12, 2019 8:30 AM ET Company Participants Gil Beyen - Chief Executive Officer Eric Soyer - Chief Financial Officer and Chief Operating Officer Iman El Hariry - Chief Medical Officer Conference Call Participants Dylan van Haaften - NIBC Operator Good day, ladies and gentlemen. And welcome to the ERYTECH Fourth Quarter and Full Year 2018 Conference Call. At this time, all participants are in a listen-only mode. [Operator Instructi...
Stock Price, News, & Analysis for Erytech Pharma
ERYTECH Pharma S.A., a biopharmaceutical company, develops therapies for severe forms of cancer and orphan diseases. It is developing a pipeline of product candidates targeting solid and liquid tumors for patients with high unmet medical needs. The company's lead product candidate is eryaspase, which is used for the treatment of severe solid tumors, including pancreatic cancer and in acute lymphoblastic leukemia. It is preparing for the launch of a pivotal Phase III clinical trial of eryaspase in the United...
-$0.51 per share